VELCADE or BORTEZOMIB
Is approved for treatment of adults with Multiple Myeloma (Cancer of the Plasma Cells).
Velcade is approved for treatment of adults with Mantle Cell Lymphoma (Cancer of the Lymph Nodes).
It can be administered via IV – Intravenously, or SC – Subcutaneously under the skin.
For more information see Link to Velcade (Bortezomib) website
632 total views, 2 views today